This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Mon Jun 17, 2013 9:33 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 7 posts ] 
Author Message
PostPosted: Sat Jan 23, 2010 2:30 pm 
Offline
Family Elder
User avatar

Joined: Sun Nov 07, 2004 4:00 pm
Posts: 1228
Location: Colorado
Yesterday, the FDA approved the marketing of the drug Fampridine - it will now be marketed under the name Ampyra
http://www.rttnews.com/ArticleView.aspx ... 839&SMap=1

Sharon


Top
 Profile  
 
 Post subject:
PostPosted: Sat Jan 23, 2010 2:50 pm 
Offline
Family Elder

Joined: Wed Jan 03, 2007 4:00 pm
Posts: 522
Location: Germany
Is it already known what the sales price at pharmacies is going to be?

--Frank

_________________
Treatment: CCSVI both IJV ballooned 09/2010, No DMDs, Tysabri on hold after 24 Infusions, after LDN, ABX Wheldon Regime for 1 year.


Top
 Profile  
 
 Post subject:
PostPosted: Sat Jan 23, 2010 3:39 pm 
Offline
Family Elder
User avatar

Joined: Sun Nov 07, 2004 4:00 pm
Posts: 1228
Location: Colorado
Frank -

Here is another link about the drug
<shortened url>

-- under the questions and answers section is information about cost
Quote:
Q. What will Ampyra cost?

A. At the present time, no information has been released about how much Ampyra therapy will cost. The company expects to release that information in coming weeks.


Sharon


Top
 Profile  
 
 Post subject:
PostPosted: Sat Jan 23, 2010 11:42 pm 
Offline
Family Elder
User avatar

Joined: Fri Jan 01, 2010 4:00 pm
Posts: 123
A nurse at my MS clinic here in Calgary, Alberta (Canada) spoke to one of the nurses involved in some of the clinical trials. She said the cost will be "astronomical" about $20,000 per year, and it is doubtful if our drug coverage program will cover it. In Canada we can expect to wait several months or a year for it to be approved once it is approved in the USA.

This is my first post here, I'll have to do an introduction at some point!


Top
 Profile  
 
 Post subject:
PostPosted: Sun Jan 24, 2010 8:58 am 
Offline
Family Elder
User avatar

Joined: Sun Nov 07, 2004 4:00 pm
Posts: 1228
Location: Colorado
$20,000 a year - oh, my gosh! And to think people have been getting this drug at compounding pharmacies for years (4-AP) at a nominal $$. There is something not in balance here!! I know, Acorda needs to get paid back for the research expense -- but, $20,000 per year?? I wonder if the US insurance companies will pay for it --

Sharon


Top
 Profile  
 
 Post subject:
PostPosted: Sun Jan 24, 2010 3:13 pm 
Offline
Family Member
User avatar

Joined: Thu Aug 13, 2009 3:00 pm
Posts: 47
Acorda has not priced this yet, they say by March. During many of their presentations at investor conf, they have indicated 5-10K but would dance around the answer when asked.

I exspect it to be some outrageous anount.

Jim


Top
 Profile  
 
 Post subject:
PostPosted: Fri Jan 29, 2010 1:43 pm 
Offline
Newbie
User avatar

Joined: Thu Sep 18, 2008 3:00 pm
Posts: 6
I wanted to share an article I wrote on Ampyra/4-aminopyridine which pulls together history of the research and patient stories. I don't know of any other place on the web which has all of this information in one place.

It would be great if folks interested would come read and comment. Obviously I don't participate much here at all, but I do occasionally come to TIMS to catch up on the latest.

Article can be found at AMPYRA™ (dalfampridine) FDA-approved for MS patients; Connie and Melissa share their stories
or http://www.healthcentral.com/multiple-s ... 100/ampyra

BTW, I am the MS blogger at http://brassandivory.blogspot.com/


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 7 posts ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Acorda Therapeutics’ Fampridine-SR likely to receive FDA app

scorpion

1

872

Sat Oct 03, 2009 6:46 am

CureOrBust View the latest post

There are no new unread posts for this topic. Acorda Therapeutics has big biotech dreams

beyondms

5

1441

Fri Jun 08, 2007 8:39 pm

CureOrBust View the latest post

There are no new unread posts for this topic. Pharmaceutical Marketing 101

NHE

2

808

Tue Dec 22, 2009 8:29 am

HarryZ View the latest post

There are no new unread posts for this topic. FDA Proposed Off-Label Marketing Rule Changes

rainer

0

942

Tue Feb 19, 2008 7:51 pm

rainer View the latest post

There are no new unread posts for this topic. fampridine reveiw by the FDA

scorpion

0

692

Thu Aug 27, 2009 9:42 am

scorpion View the latest post

 


Who is online

Users browsing this forum: danirs


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to:  


News News Site map Site map SitemapIndex SitemapIndex RSS Feed RSS Feed Channel list Channel list
Read hundreds of personal Multiple Sclerosis stories on Experience Project. Experience Project is an anonymous community where people connect through their life experiences, made by the same people who built This is MS. With over 30 million personal stories about every possible life experience, you can quickly find people like you!


Interesting: Secret Confessions | Dream Meanings | Ask Questions, Get Answers

Advertise on the premier multiple sclerosis forum